207 related articles for article (PubMed ID: 11904448)
1. Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons.
Alves da Costa C; Paitel E; Mattson MP; Amson R; Telerman A; Ancolio K; Checler F
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):4043-8. PubMed ID: 11904448
[TBL] [Abstract][Full Text] [Related]
2. The C-terminal fragment of presenilin 2 triggers p53-mediated staurosporine-induced apoptosis, a function independent of the presenilinase-derived N-terminal counterpart.
Alves da Costa C; Mattson MP; Ancolio K; Checler F
J Biol Chem; 2003 Apr; 278(14):12064-9. PubMed ID: 12556443
[TBL] [Abstract][Full Text] [Related]
3. Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells.
Ramalho RM; Borralho PM; Castro RE; Solá S; Steer CJ; Rodrigues CM
J Neurochem; 2006 Sep; 98(5):1610-8. PubMed ID: 16923170
[TBL] [Abstract][Full Text] [Related]
4. Pro-apoptotic effect of presenilin 2 (PS2) overexpression is associated with down-regulation of Bcl-2 in cultured neurons.
Araki W; Yuasa K; Takeda S; Takeda K; Shirotani K; Takahashi K; Tabira T
J Neurochem; 2001 Dec; 79(6):1161-8. PubMed ID: 11752057
[TBL] [Abstract][Full Text] [Related]
5. Contrasting role of presenilin-1 and presenilin-2 in neuronal differentiation in vitro.
Hong CS; Caromile L; Nomata Y; Mori H; Bredesen DE; Koo EH
J Neurosci; 1999 Jan; 19(2):637-43. PubMed ID: 9880584
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of wild-type presenilin 2 or its familial Alzheimer's disease-associated mutant does not induce or increase susceptibility to apoptosis in different cell lines.
Gamliel A; Teicher C; Hartmann T; Beyreuther K; Stein R
Neuroscience; 2003; 117(1):19-28. PubMed ID: 12605888
[TBL] [Abstract][Full Text] [Related]
7. Presenilin overexpression arrests cells in the G1 phase of the cell cycle. Arrest potentiated by the Alzheimer's disease PS2(N141I)mutant.
Janicki SM; Monteiro MJ
Am J Pathol; 1999 Jul; 155(1):135-44. PubMed ID: 10393846
[TBL] [Abstract][Full Text] [Related]
8. Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues.
Lee MK; Slunt HH; Martin LJ; Thinakaran G; Kim G; Gandy SE; Seeger M; Koo E; Price DL; Sisodia SS
J Neurosci; 1996 Dec; 16(23):7513-25. PubMed ID: 8922407
[TBL] [Abstract][Full Text] [Related]
9. Presenilin-dependent gamma-secretase-mediated control of p53-associated cell death in Alzheimer's disease.
Alves da Costa C; Sunyach C; Pardossi-Piquard R; Sévalle J; Vincent B; Boyer N; Kawarai T; Girardot N; St George-Hyslop P; Checler F
J Neurosci; 2006 Jun; 26(23):6377-85. PubMed ID: 16763046
[TBL] [Abstract][Full Text] [Related]
10. Neurons overexpressing mutant presenilin-1 are more sensitive to apoptosis induced by endoplasmic reticulum-Golgi stress.
Terro F; Czech C; Esclaire F; Elyaman W; Yardin C; Baclet MC; Touchet N; Tremp G; Pradier L; Hugon J
J Neurosci Res; 2002 Aug; 69(4):530-9. PubMed ID: 12210846
[TBL] [Abstract][Full Text] [Related]
11. Presenilins mediate phosphatidylinositol 3-kinase/AKT and ERK activation via select signaling receptors. Selectivity of PS2 in platelet-derived growth factor signaling.
Kang DE; Yoon IS; Repetto E; Busse T; Yermian N; Ie L; Koo EH
J Biol Chem; 2005 Sep; 280(36):31537-47. PubMed ID: 16014629
[TBL] [Abstract][Full Text] [Related]
12. Interaction of Alzheimer's presenilin-1 and presenilin-2 with Bcl-X(L). A potential role in modulating the threshold of cell death.
Passer BJ; Pellegrini L; Vito P; Ganjei JK; D'Adamio L
J Biol Chem; 1999 Aug; 274(34):24007-13. PubMed ID: 10446169
[TBL] [Abstract][Full Text] [Related]
13. Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's disease.
Mathews PM; Cataldo AM; Kao BH; Rudnicki AG; Qin X; Yang JL; Jiang Y; Picciano M; Hulette C; Lippa CF; Bird TD; Nochlin D; Walter J; Haass C; Lévesque L; Fraser PE; Andreadis A; Nixon RA
Mol Med; 2000 Oct; 6(10):878-91. PubMed ID: 11126202
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease presenilin-1 exon 9 deletion and L250S mutations sensitize SH-SY5Y neuroblastoma cells to hyperosmotic stress-induced apoptosis.
Tanii H; Ankarcrona M; Flood F; Nilsberth C; Mehta ND; Perez-Tur J; Winblad B; Benedikz E; Cowburn RF
Neuroscience; 2000; 95(2):593-601. PubMed ID: 10658639
[TBL] [Abstract][Full Text] [Related]
15. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors.
Thinakaran G; Harris CL; Ratovitski T; Davenport F; Slunt HH; Price DL; Borchelt DR; Sisodia SS
J Biol Chem; 1997 Nov; 272(45):28415-22. PubMed ID: 9353300
[TBL] [Abstract][Full Text] [Related]
16. Nerve growth factor withdrawal-mediated apoptosis in naive and differentiated PC12 cells through p53/caspase-3-dependent and -independent pathways.
Vaghefi H; Hughes AL; Neet KE
J Biol Chem; 2004 Apr; 279(15):15604-14. PubMed ID: 14739302
[TBL] [Abstract][Full Text] [Related]
17. Bcl-X(L)-caspase-9 interactions in the developing nervous system: evidence for multiple death pathways.
Zaidi AU; D'Sa-Eipper C; Brenner J; Kuida K; Zheng TS; Flavell RA; Rakic P; Roth KA
J Neurosci; 2001 Jan; 21(1):169-75. PubMed ID: 11150333
[TBL] [Abstract][Full Text] [Related]
18. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease.
Kim TW; Pettingell WH; Jung YK; Kovacs DM; Tanzi RE
Science; 1997 Jul; 277(5324):373-6. PubMed ID: 9219695
[TBL] [Abstract][Full Text] [Related]
19. Restoration of transforming growth factor-beta signaling enhances radiosensitivity by altering the Bcl-2/Bax ratio in the p53 mutant pancreatic cancer cell line MIA PaCa-2.
Ahmed MM; Alcock RA; Chendil D; Dey S; Das A; Venkatasubbarao K; Mohiuddin M; Sun L; Strodel WE; Freeman JW
J Biol Chem; 2002 Jan; 277(3):2234-46. PubMed ID: 11694525
[TBL] [Abstract][Full Text] [Related]
20. Caspase-dependent cytosolic release of cytochrome c and membrane translocation of Bax in p53-induced apoptosis.
Gao CF; Ren S; Zhang L; Nakajima T; Ichinose S; Hara T; Koike K; Tsuchida N
Exp Cell Res; 2001 Apr; 265(1):145-51. PubMed ID: 11281652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
